MORGAN STANLEY

Holdings History for Evoke Pharma Inc - Common Stock, par value $0.0001 per share (EVOK)

Symbol: EVOK
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 31 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK)

05 Dec 2025 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 31 shares of Evoke Pharma Inc Common Stock, par value $0.0001 per share (EVOK). This represents 0% ownership of the company. In their previous filing dated 08 Sep 2025, MORGAN STANLEY had reported owning 163,718 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Morgan Stanley	0%	-95%	$331	31	-163,687	-100%	$10.69	13G/A	30 Nov 2025	05 Dec 2025, 16:03
Morgan Stanley	10%		$807,130	163,718			$4.93	13G	31 Aug 2025	08 Sep 2025, 16:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-159,358	-100%	$10.80	Q4 2025
30 Sep 2025	0%	+0%	$792,009	159,358	+159,294	+248897%	$4.97	Q3 2025
30 Jun 2025	0%	0%	$166	64	0		$2.59	Q2 2025
31 Mar 2025	0%	0%	$176	64	+33	+100%	$2.75	Q1 2025
31 Dec 2024	0%	0%	$137	31	0		$4.42	Q4 2024
30 Sep 2024	0%	0%	$148	31	+31	NEW	$4.77	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.